Featured Courses

Module 2 - New Understanding of COPD Pathophysiology and Emerging Biologic Therapies

Pulmonary Disease

Course Description: This module covers recent advances in COPD management, including an update on pathophysiology, the e...

The Impact of Non-seizure Symptoms in Patients with Developmental and Epileptic Encephalopathies

Neurology

Course Description: This module gives an overview of DEEs and their non-seizure symptoms, and why these symptoms are imp...

The Anti-seizure Medication Landscape and Their Effect on Non-seizure Symptoms

Neurology

Course Description: This module discusses the major anti-seizure medicines used for patients with DEEs and how they impa...

Collaborative Care with NSS (Non-Seizure Symptoms) in Mind

Neurology

Course Description: This module discusses the importance of individualizing care for patients with DEEs and reviews the...

COURSES

ALL

Advancements in ADC Therapy for Metastatic Triple Negative and HER+/HER2- Breast Cancer Treatment

LAUNCH DATE: 23-Dec-2024

EXPIRATION DATE: 23-Dec-2025

Oncology

CREDITS

0.75 AMA PRA Category 1 Credit(s)™

Antibody Drug Conjugates (ADC) - United States

LAUNCH DATE: 11-Sep-2024

EXPIRATION DATE: 11-Sep-2025

Oncology

CREDITS

0.50 AMA PRA Category 1 Credit(s)™

0.50 ANCC Contact Hours

0.50 ACPE

0.50 Pharmacology

Collaborative Care with NSS (Non-Seizure Symptoms) in Mind

LAUNCH DATE: 30-Sep-2024

EXPIRATION DATE: 30-Sep-2025

Neurology

CREDITS

0.25 AMA PRA Category 1 Credit(s)™

Defining the therapeutic algorithm in patients with HR positive breast cancer - United States

LAUNCH DATE: 11-Sep-2024

EXPIRATION DATE: 11-Sep-2025

Oncology

CREDITS

0.50 AMA PRA Category 1 Credit(s)™

0.50 ANCC Contact Hours

0.50 ACPE

0.50 Pharmacology

Module 1 - Overview of COPD and Optimal Standard-of-Care Therapy

LAUNCH DATE: 02-Dec-2024

EXPIRATION DATE: 02-Dec-2025

Pulmonary Disease

CREDITS

0.25 AMA PRA Category 1 Credit(s)™